The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

proacta.com

Proacta has not claimed their Profile.

Want to better differentiate Proacta between your competitors? Show buyers how.

PNP Therapeutics company logo

Why does Proacta win vs. PNP Therapeutics?

Show Proacta's primary competitive advantage

Show Proacta's competitive differentiation

Proacta's alternatives and competitors

See how Proacta compares to similar products. Proacta's top competitors include PNP Therapeutics, GANYMED Pharmaceuticals, and Nutrinia.

PNP Therapeutics is dedicated to the development and commercialization of a cancer treatment approach that is predicated on well-documented evidence that solid tumors c…

Proacta vs. PNP Therapeutics

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
  • Ganymed Pharmaceuticals is a biopharmaceutical company that researches, develops, and produces pharmaceutical products and therapeutic drugs for the treatment of solid …

    Proacta vs. GANYMED Pharmaceuticals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Nutrinia is a neonatology company focused on developing a proprietary oral formulation of insulin for gastrointestinal indications in infants.

    Proacta vs. Nutrinia

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • LIDDS (Local Intelligent Drug Delivery System) is a Swedish pharmaceutical company developing innovative pharmaceutical products based on medical need and its proprieta…

    Proacta vs. LIDDS

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Algeta is focused on developing, manufacturing and marketing novel targeted therapies for patients with cancer. The company is headquartered in Oslo, Norway, and has a …

    Proacta vs. Algeta

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Veracyte is a molecular diagnostics company in the field of molecular cytology. The company is focused on discovering, developing and commercializing molecular diagnost…

    Proacta vs. Veracyte

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Nanobiotix (NASDAQ: NBTX) is a nanomedicine company focused on radiotherapy, and aiming to make it more deadly to tumors while preserving the surrounding healthy tissue…

    Proacta vs. Nanobiotix

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Chimeros is developing a biologics approach to enable delivery of polynucleotide therapeutics such as siRNAs. The company's delivery technology, termed Chimerasomes, is…

    Proacta vs. Chimeros

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Therion Biologics Corporation is engaged in the development of therapeutic vaccines for cancer and preventive vaccines for AIDS. The company has three lead programs inv…

    Proacta vs. Therion Biologics

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • CoTherix is dedicated to the development and commercialization of improved therapies for inflammatory lung diseases. The company was formed in 2000 with the initial foc…

    Proacta vs. CoTherix

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Chiome Bioscience leverages the ADLib® System, a proprietary monoclonal antibody generating technology for drug development. The company also provides drug discovery su…

    Proacta vs. Chiome Bioscience

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • ModiQuest (CRO) focus is on generation of recombinant monoclonal antibodies (animal, human). The company use antigen specific B-cell selection combined with efficient h…

    Proacta vs. ModiQuest

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • CellSignals applies its technology in chiral synthesis to develop lipid mediators pertinent to intracellular signal transduction and cancer biology. Currently CellSigna…

    Proacta vs. CellSignals

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Evogenix aims to provide advanced technologies to provide powerful new antibody therapeutics for world markets.

    Proacta vs. Evogenix

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more

Work for Proacta?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

A
Agenta Biotechnologies

Agenta's technologies capitalize on variations of the important biomolecules called proteoglycans, a class of molecules that can promote healing through a variety of known mechanisms. As therapeutics, they can be applied to bone and skin, or serve as coatings for various devices. It is Agenta's mission to be the world provider in manipulating proteoglycans for therapeutic use.

O
Onyvax

Onyvax is developing new cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells. Onyvax's products specifically target cancer cells, increasing the likelihood that they will be effective while minimising side effects associated with many conventional treatments. These therapies can broadly be classed as therapeutic cancer vaccines. Onyvax's lead product is in clinical trials for the treatment of prostate cancer and is poised to enter the final stages of development. Onyvax is committed to the commercialisation of therapies that enhance survival while maintaining a high quality of life for patients. The Company is based in London and has collaborations with leading hospitals and other institutions throughout Europe and the US.

P
Pro-Cure Therapeutics

Prostate Cancer - Pro-Cure Therapeutics - Enabling the development of a cure for prostate cancer based on stem cells

T
TenX Biopharma

TenX is a biopharmaceutical company focused on late stage development and launch of novel cancer products.

C
CellSignals

CellSignals applies its technology in chiral synthesis to develop lipid mediators pertinent to intracellular signal transduction and cancer biology. Currently CellSignals' product line has grown to more than 40 chemicals covering a variety of inositol polyphosphates and phosphatidylinositol polyphosphates. CellSignals is actively developing small-molecules, orally bio-available therapeutics for the treatments of breast, skin cancers, and leukemia.

F
Femta Pharmaceuticals

Femta is developing a new generation of antibody therapeutics for major disease indications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.